This page is part of the Adverse Event Clinical Research R4 Backport (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
Generated Narrative: AdverseEvent
Resource AdverseEvent "adverse-event-compass-ex1b"
Profile: Adverse Event Clinical Research
Severity Or Grade: Mild (AdverseEvent Severity or Grade Codes#1)
Participant
url
function
value: authenticator (ParticipationType#AUTHEN)
url
actor
value: Practitioner/practitioner-owen-oncologist " ONCOLOGIST"
Suspect Entity
url
instance
value: MedicationAdministration/medication-administration-kadcyla
url
causality
Suspect Entity
url
instance
value: MedicationAdministration/medication-administration-tucatinib
url
causality
Expected In Research Study: true
Adverse Event resolution date: 2020-06-10
Note: treatment given with reduced dose per protocol guidelines
Mitigating Action
url
item
value: MedicationAdministration/medication-administration-kadcyla-reduced
Mitigating Action
url
item
value: MedicationAdministration/medication-administration-tucatinib-reduced
modifierExtension[http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/status]
actuality: actual
event: Alanine aminotransferase (ALT) decreased to 60 (www.meddra.org#10001551 "Alanine aminotransferase increased")
subject: Patient/patient-example-kaitlyn-b " BOUNCE"
date: 2020-05-20
seriousness: Non-serious (AdverseEventSeriousness#non-serious)
outcome: C49498"Recovered/Resolved" (NCI Thesaurus#C49498"Recovered/Resolved")
recorder: Practitioner/practitioner-oncology-nurse-jane " NURSE"